In summary, ghrelin is a regulator of GLP-1 secretion and transcription, and interfering with GHS-R1a signaling may be a way forward to enhance endogenous GLP-1 secretion in subjects with type 2 diabetes
Cost and access : Both medications are expensive, and sermorelin for metabolic purposes is rarely covered by insurance, creating significant financial burden without guaranteed benefit
Important Note: Growth hormone peptides have been under increased regulatory scrutiny in recent years, particularly when marketed for wellness programs or performance enhancement
Cell Rep 25(8):20832093 Kwon N, Thompson EN, Mayday MY, Scanlon V, Lu YC, Krause DS (2021) Current understanding of human megakaryocytic-erythroid progenitors and their fate determinants
Immunoglobulins on the surface of differently charged polymer nanoparticles